Karus Therapeutics presenting at BioTrinity 2015

Simon Kerry, CEO of Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, will be attending and presenting at BioTrinity 2015, 11-13 May 2015 in Oxford, UK.

For more information on Karus’s presentations or for media enquiries, please contact karus@instinctif.com.